http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008535795-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate | 2006-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2008535795-A |
| titleOfInvention | Tyrosine kinase inhibitor compositions and methods for their manufacture and use in the treatment of disease |
| abstract | New erbB-based ligand binding molecules are disclosed along with methods for their preparation and use. The binding molecule is a protein expressed from a recombinant DNA molecule. The protein includes an erbB extracellular domain that binds to an active ligand. These binding components act as traps that bind and sequester circulating ligands, making them unable to bind to cellular erbB receptors. |
| priorityDate | 2005-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 129.